Your browser doesn't support javascript.
loading
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against Ebola.
Bockstal, Viki; Leyssen, Maarten; Heerwegh, Dirk; Spiessens, Bart; Robinson, Cynthia; Stoop, Jeroen N; Roozendaal, Ramon; Van Effelterre, Thierry; Gaddah, Auguste; Van Roey, Griet A; Solforosi, Laura; Zahn, Roland; Callendret, Benoit; Hendriks, Jenny; Luhn, Kerstin; Douoguih, Macaya; Schuitemaker, Hanneke; Van Hoof, Johan.
Afiliación
  • Bockstal V; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Leyssen M; ExeVir, Ghent, Belgium.
  • Heerwegh D; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Spiessens B; University of Leuven, Leuven, Belgium.
  • Robinson C; Janssen Research and Development, Beerse, Belgium.
  • Stoop JN; Janssen Research and Development, Beerse, Belgium.
  • Roozendaal R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Van Effelterre T; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Gaddah A; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Van Roey GA; Janssen Research and Development, Beerse, Belgium.
  • Solforosi L; Janssen Research and Development, Beerse, Belgium.
  • Zahn R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Callendret B; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Hendriks J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Luhn K; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Douoguih M; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Schuitemaker H; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands. kluhn@its.jnj.com.
  • Van Hoof J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
NPJ Vaccines ; 7(1): 156, 2022 Nov 30.
Article en En | MEDLINE | ID: mdl-36450746
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Vaccines Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: NPJ Vaccines Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos